Pharma IQ Members

Podcasts

Pharma IQ provides learning opportunities through our pharma and biotech podcast series. Listen to pharma podcasts on Pharma IQ and enhance your pharma and biotech learning. A pharma podcast features a one-on-one interview or panel discussion with pharma experts. Listen, subscribe and learn today. 

356 results
of 15

Utilising Big Data for Bioscience Product Development

Wed, 07/02/2014
Big data is turning up everywhere. In this Process Perspectives podcast, Kaare Buch Petersen, Information Architect in Global IT at Christen Hansen, a Denmark-based supplier of bioscience products to food and health industries, talks about how his company has been using big data in the development of their new products. Editor's note: read a...
Listen now


Fewer Robots, More Apps - An Interview with Jeff Hurst

Mon, 03/24/2014
The informatics landscape is changing quickly and innovation could be the key to increasing efficiency. Jeff Hurst, Senior Scientist at the Hershey's Company talks us through these changes and how the industry is moving away from robots towards more innovative methods including mobile apps. He also talks about the dangers of becoming overly '...
Listen now


What Pharma can Learn from the Food & Beverage Industry -- An Interview with Pepsico's Steve Hills

Wed, 03/12/2014
The pharma industry has a lot to learn from the food and beverage industry when it comes to contract manufacturing. To get to grips with this outsider's view, we spoke with Steve Hills, European Contract Manufacturing Director at Pepsico. Steve outlines where companies can go wrong in working with CMOs
Listen now


From Tactical to Strategic Thinking; The Change in CMO Relationships - An Interview with Jim Browne

Tue, 03/04/2014
Where can companies go wrong in their relationship with a CMO and what have been the major changes in these relationships in recent years? We spoke with Jim Browne, former Director of External Supply at GlaxoSmithKline and currently Director at JTB Consultancy Ltd to find out the answers to these questions. Jim also talks about they key to...
Listen now


Futureproof your Biobank - An Interview with Kathi Shea

Tue, 02/18/2014
Biobanks must face a broad range of demands during their operation and this must be taken into account in strategies and planning. Ahead of the Biobanking 2014 conference we spoke to Kathi Shea, former President of ISBER and Vice President BioServices, Precision for medicine. Kathi spoke about procedures and training increase the value of...
Listen now


Building an Effective Informatics System at UK Biobank - An Interview with James Brennan

Wed, 02/12/2014
Most people understand that one of the greatest challenges with new technology or processes is getting them to integrate with existing systems. We spoke with James Brennan, Informatics Lead at the UK Biocentre about integrating their sample ordering system with an existing LIMS. We also spoke about the challenges involved in a sample ordering...
Listen now


Inside Development of Lundbeck’s Inhouse Global Compound Management and Compound Ordering System - An Interview with Claus Stie Kallesøe

Tue, 02/11/2014
Creating a fit-for-purpose compound management and compound ordering system is a huge task, so often the best way to understand is to look at those who have done it before. We spoke to Claus Stie Kallesøe, Head of Research Informatics at Lundbeck about his experiences in this task and how it was completed from inception to completion. Claus also...
Listen now


Ben Goldacre Makes the Case for Greater Transparency in Clinical Trials

Mon, 01/20/2014
"Clinical trial information is being routinely and legally witheld and this needs to end". This is the assertion of Dr. Ben Goldacre; a doctor, science writer, campaigner on scientific issues including clinical trial transparency and author of the book Bad Pharma. Pharma IQ discussed the issue of clinical trial transparency with Dr. Goldacre, with...
Listen now


Gawayne Mahboubian-Jones on International Standards to Support the Application of Process Analytical Technology

Sun, 01/12/2014
In this interview Gawayne Mahboubian-Jones, Manager of Quality by Design for Philip Morris International, shares his views on international standards to support the application of Process Analytical Technology and key quality by design (QbD) trends in manufacturing. Mahboubian-Jones also discusses the internal cultural change required to...
Listen now


Reducing Safety-Related Drug Attrition- An Interview with Gareth Waldron

Sun, 12/15/2013
Safety-related drug attrition is obviously a huge problem in drug trials. How can companies work to reduce this? We spoke with Gareth Waldron Non-Clinical Safety Lead at Pfizer Neusentis about in vitro pharmacological profiling, how it could be implemented to reduce this attrition and the success stories so far.
Listen now


Desmond Hunt on Expectations for the New Chapter from the USP regarding Single-Use Systems

Tue, 12/10/2013
Desmond Hunt, Senior Scientific Liaison, United States Pharmacopoeia (USP), speaks to Andrea Charles from Pharma IQ, about the current standards and guidance for single-use systems and the expectations for the new chapter from the USP regarding single-use systems. Hunt also shares his insights on challenges for extractables and leachables...
Listen now


Implementing Single-Use Biomanufacturing Systems: What are the Challenges Ahead?

Sun, 12/01/2013
In this Pharma IQ interview Tony Hitchcock, Technical Director at Cobra Biologics, speaks to Andrea Charles from Pharma IQ, about why single use systems are not implemented more commonly across the biomanufacturing industry and the challenges surrounding scale up. Hitchcock also shares his top 3 tips for implementing single use systems today and...
Listen now


Clinical Trial Supply Case Study: Bial - An Interview with Ricardo Lima

Thu, 11/28/2013
Smaller companies face differing challenges in Clinical Trial Supply, but they also have their own unique advantages. We spoke to Ricardo Lima, Head of Pharmaceutical Development at Bial Research & Development about Bial's experiences.He discussses comparator sourcing, forecasting and working in emerging markets in this detailed case study...
Listen now


Reducing Late-Stage Biologic Failure with Immune Assays- An Interview with Harald Kropshofer

Wed, 11/27/2013
There have been some high profile cases of antibodies causing severe reactions, as well as posing a high risk to patients, these late stage failures are hugely costly. Is there a way to prevent or predict these immune reactions to biologics? We spoke to Harald Kropshofer Senior Personalized Healthcare Leader, Pharmaceutical Development F. Hoffman...
Listen now


New Territory: Extractables & Leachables in Disposable and Single-Use Manufacturing Systems

Sun, 11/24/2013
In this exclusive interview Alain Pralong, VP New Product Introduction and Technical Life Cycle Management at GlaxoSmithKline Vaccines, speaks to Andrea Charles from Pharma IQ, about the challenges faced evaluating single-use systems for extractables and leachables and implementing single-use technology in biopharmaceutical manufacturing....
Listen now


Forecasting a Brighter Future for Clinical Trial Supply in Emerging Markets- An Interview with Adrian Peskett

Tue, 11/12/2013
Pharma IQ interviewed Adrian Peskett, Clinical Supply Logistics Director at Pfizer Ltd. about his predictions for the future of clinical trial supply in emerging markets. Adrian also speaks about the importance of forecasting in emerging markets and the difficulties in standardising strategy, while meeting countries' individual needs.
Listen now


Site Perspectives on Clinical Trial Supply- An Interview with Samantha Carmichael

Mon, 11/04/2013
Should companies be communicating more clearly with their site teams with regard to their expectations? We spoke to Samantha Carmichael, Lead Pharmacist Clinical Trials at NHS Greater Glasgow & Clyde to gain insight into challenges for sites from the different stages in clinical supply management.
Listen now


Ensuring Smooth Regulatory Submissions in Software for Medical Devices- An Interview with Arnab Ray

Mon, 11/04/2013
Many companies struggle to understand regulatory expectations of their submissions which can lead to long and costly delays. We spoke to Arnab Ray, Senior Research Scientist at the Franuhofer Center who gave us his key points to ensuring a smooth regulatory submission process
Listen now


Complexity Conundrum: New Threats to Medical Device Security- An Interview with Arnab Ray

Mon, 11/04/2013
With increasing software sophistication and complexity, are security vulnerabilities an inevitability? We spoke with Arnab Ray, Senior Research Scientist at the Franuhofer Center about the issues surrounding device security and how the will effect companies in the coming years.
Listen now


3D Stem Cell Assays in Space?- An Interview with NASA's Dr Tom Goodwin

Mon, 11/04/2013
Why are NASA using human stem cells to study the chicken pox virus? How could this help astronauts in space?  How is the Mars Rover mission helping?  And why are the Russians so interested?  Find out with Thomas J. Goodwin, Manager, Disease Modelling/Tissue Analogues Laboratory at NASA's Johnson Space Centre, in our latest podcast
Listen now


Regulatory Impact on Medical Devices - An Interview with Chuck Sidebottom

Tue, 10/29/2013
With over 30 years in the industry, Chuck Sidebottom Director of Corporate Standards at Medtronic is excellently placed to analyse trends in the medical device industry. When he spoke with Pharma IQ, Chuck discussed recent shifts in regulatory emphasis and predicted how this emphasis will change in the future. He also discussed the importance of...
Listen now


Semi-Synthetic Artemisinin - The Beginning of the SynthBio Revolution? - An Interview with Jay Keasling

Fri, 11/01/2013
Artemisinin is a front line anti-malarial drug which was derived from the sweet wormwood plant. ‘Growing on trees’ however, isn’t all it’s cracked up to be and the supply could be unpredictable.  Professor Jay Keasling, using synthetic biology techniques, had grown his own artemisinin in the lab and with support from the Bill and Melinda Gates...
Listen now


Will in vitro/in silico Methods Ever Replace in vivo Methods in Toxicology? - An Interview with Jorrit Hornberg

Thu, 10/17/2013
Ahead of the Cell Based Assays Conference in December, Pharma IQ spoke with Jorrit Hornberg about the advances in vitro and in silico predictive toxicology and what this means for in vivo assays. He also spoke about the challenges in incorporating predictive toxicology into drug development.
Listen now


In the Know, Industry Views on Pathogen Safety: Conversation with John Shah

Wed, 10/16/2013
How do you find out the industry opinion on a topic? Simply, speak with them. Senior Conference Producer John Shah has spoken with hundreds of professionals working in pathogen safety from industry and regulatory perspectives. Our Editor Gerald Clarke spoke to him about what he has learned from these conversations.
Listen now


NASA Study Part I- Modelling Disease with Human Neuron 3D Assays: Interview with Benedikt Kaufer

Mon, 10/07/2013
Benedikt B. Kaufer Project Director, Institute for Virologyat the Freie Universität Berlin speaks about his remarkable NASA-funded study published in Plos Pathology. The paper regarded using Tissue Like Arrays (TLAs) for modelling disease in human neurons. Varicella zoster Virus (VZV) is difficult to model in cell cultures due to their short...
Listen now


356 results
of 15